SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Unicycive Therapeutics, Inc. Common Stock

UNCY XNAS
$3.35 -0.12 (-3.40%) ▼ 15-min delayed
Open
$3.51
High
$3.62
Low
$3.35
Volume
1.36M
Market Cap
$97.77M

About Unicycive Therapeutics, Inc. Common Stock

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 22 Website →

Related Market News

No specific coverage for UNCY yet. Check out our latest market news or earnings calendar.

Get UNCY Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Unicycive Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.